You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Fertility, pregnancy and childbirth
  5. Postnatal care

Zuranolone for treating postnatal depression [ID6431]

  • In development
  • Reference number: GID-TA11356
  • Expected publication date: TBC
  • Project information
  • Project documents

On this page

  1. Draft guidance: 1
  2. Declaration of interests
  3. Invitation to participate
  4. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6431

Documents

Documents created during the development process.

Draft guidance: 1

  • Draft guidance: 1

  • Draft consultation document (online commenting)

  • Draft guidance (downloadable version) (PDF 276 KB)

    Published:
    28 August 2025
  • Equality impact assessment (downloadable version) (PDF 131 KB)

    Published:
    28 August 2025
  • Committee papers (PDF 4.87 MB)

    Published:
    28 August 2025
  • Public committee slides (PDF 796 KB)

    Published:
    28 August 2025

Declaration of interests

  • Register of interests (PDF 143 KB)

    Published:
    27 August 2025

Invitation to participate

  • Final scope (PDF 230 KB)

    Published:
    09 January 2025
  • Final stakeholder list (PDF 56 KB)

    Published:
    09 January 2025
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 282 KB)

    Published:
    09 January 2025
  • Equality impact assessment (scoping) (PDF 122 KB)

    Published:
    09 January 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6431

  • Draft matrix post referral (PDF 193 KB)

    Published:
    16 September 2024
  • Draft scope post referral (PDF 234 KB)

    Published:
    16 September 2024
Back to top